DocSym
β
Searchsearch
Search
(P61.6) Other transient neonatal disorders of coagulation
More details coming soon
325 367 in individuals diagnosis other transient neonatal disorders of coagulation confirmed
3 002 deaths with diagnosis other transient neonatal disorders of coagulation
1% mortality rate associated with the disease other transient neonatal disorders of coagulation
Diagnosis other transient neonatal disorders of coagulation is diagnosed Men are 12.21% more likely than Women
182 547
Men receive the diagnosis other transient neonatal disorders of coagulation
1 628 (0.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
142 820
Women receive the diagnosis other transient neonatal disorders of coagulation
1 374 (1.0 %)Died from this diagnosis.
Risk Group for the Disease other transient neonatal disorders of coagulation - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 5-29, 35-49, 55-95+
In Women diagnosis is most often set at age 0-5, 30-34, 50-54
Disease Features other transient neonatal disorders of coagulation
Absence or low individual and public risk
Other transient neonatal disorders of coagulation - what does this mean
Other transient neonatal disorders of coagulation are caused by an immature or deficient coagulation system in newborns, which can lead to an increased risk of bleeding. this is usually due to an inherited disorder, a deficiency of coagulation factors, or an acquired factor such as maternal medication or infection.
What happens during the disease - other transient neonatal disorders of coagulation
Other transient neonatal disorders of coagulation are a group of inherited and acquired disorders that can cause bleeding in newborns. these disorders are caused by a variety of factors, including deficiencies in clotting factors, platelet dysfunction, and abnormal fibrinogen levels. in some cases, the cause of the disorder is unknown. these disorders can cause bleeding from the umbilical cord, skin, gums, and other sites. treatment usually involves replacement of the deficient clotting factor or platelet transfusions, and may also involve treating any underlying conditions that may have caused the disorder.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count
- Platelet count
- Prothrombin time (PT) and activated partial thromboplastin time (aPTT)
- Thrombin time (TT)
- Fibrinogen levels
- D-dimer levels
- Lupus anticoagulant test
- Anticardiolipin antibody test
- Factor VIII and IX activity assays
- Plasma protein electrophoresis
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To treat Other transient neonatal disorders of coagulation.
- Administering fresh frozen plasma or cryoprecipitate
- Administering vitamin K
- Monitoring of blood clotting times
- Monitoring of bleeding episodes
- Administering antifibrinolytic agents
- Administering transfusions of packed red blood cells
- Monitoring of platelet count
- Administering platelet transfusions
- Administering immunoglobulin
- Administering antibiotics
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other transient neonatal disorders of coagulation - Prevention
Transient neonatal disorders of coagulation can be prevented through proper antenatal care, including adequate nutrition and vitamin k supplementation for the mother during pregnancy. additionally, newborns should be given a dose of vitamin k shortly after birth to prevent any coagulation disorders.